Markets

Q1 Growth EPP Deal Making Sets Strong Pace

By |

Growth issuers and investors have conducted equity private placements at a brisk pace this year, making the first quarter the most active early-year period in three years. The continued life science bull market and IPO run fueled much of the activity in growth equity private placements (EPPs) – offerings of a least $1 million of stock or equity-linked debt that feature fixed purchase, conversion and warrant exercise price terms, and that are sold by companies with market capitalizations from $10 million to $1 billion. However, mixed messages from the Federal Reserve about interest rates and fears about a market correction, particularly in the life science sector where investors have apparently swung to a “risk off” posture, could temper enthusiasm for EPPs in the coming weeks. While EPP deal making remained resilient through the first half of April, four companies postponed IPOs, including two biotech issuers, as broad selloffs hit the market. Growth companies raised $3.9 billion in 199 common stock, convertible and non-convertible growth EPPs in the first three months of 2014 for an average deal size of $19.6 million, according to PlacementTracker, a division of Sagient Research.

News

Infinity Cross Border SPAC Completes Merger with Glori Energy

By |

Glori Energy, an energy technology company, and SPAC Infinity Cross Border Acquisition Corp. (INXB) have completed their merger announced on January 8. The merger included a simultaneous private placement led by Infinity Group and Hicks Equity Partners. Commencing April 15, 2014, shares and warrants of Glori will be publicly listed on the Nasdaq Capital Market under the ticker symbols GLRI and GLRIW, respectively. On April 15 the shares and warrants of Glori were listed on Nasdaq Capital Market under the ticker symbols GLRI and GLRIW, respectively.